|1.||Luszczki, Jarogniew J: 13 articles (03/2015 - 10/2003)|
|2.||Gilron, Ian: 13 articles (02/2015 - 01/2005)|
|3.||Loprinzi, Charles L: 13 articles (11/2014 - 05/2003)|
|4.||Ono, Hideki: 13 articles (01/2014 - 12/2004)|
|5.||Granados-Soto, Vinicio: 12 articles (02/2015 - 01/2003)|
|6.||Guttuso, Thomas: 12 articles (10/2014 - 02/2003)|
|7.||Tanabe, Mitsuo: 11 articles (12/2009 - 12/2004)|
|8.||Moore, R Andrew: 10 articles (01/2015 - 08/2008)|
|9.||Sweeney, Michael: 9 articles (10/2015 - 01/2012)|
|10.||Eisenach, James C: 9 articles (10/2014 - 03/2007)|
11/26/2002 - "Patients whose symptoms included pain benefited most from gabapentin. "
11/01/2014 - "There is evidence to suggest that gabapentin is safe and effective in reducing opioid consumption and pain scores at optimal doses of 600-900 mg orally administered preoperatively. "
03/01/2008 - "After surgery, the patient continued to experience pain; however, his pain resolved completely after several weeks of receiving gabapentin 600 mg 3 times/day. "
04/01/2002 - "Of five patients with sensory deficits who tolerated gabapentin therapy, three showed marked improvement of their sensory deficits associated with pain alleviation. "
01/01/2015 - "Finally, the pain was successfully relieved by gabapentin as an adjuvant to tramal. "
|2.||Neuralgia (Stump Neuralgia)
06/01/2004 - "Ease of use and broad therapeutic range, in addition to demonstrated efficacy, make gabapentin the drug of choice for most neuropathic pain disorders. "
01/01/2012 - "The anticonvulsant gabapentin has been proven effective for treating neuropathic pain in large placebo-controlled clinical trials. "
09/01/2002 - "The anticonvulsant gabapentin has proven effective for neuropathic pain in three large placebo-controlled clinical trials. "
01/01/2014 - "Second tier evidence, with potentially important residual biases, showed that gabapentin at doses of 1200 mg or more was effective for some people with some painful neuropathic pain conditions. "
09/01/2012 - "The results of this study show that gabapentin is effective in acute herpetic neuralgia in different doses with 600 mg/day being the more appropriate dose in terms of safety and efficacy."
06/01/2000 - "The objective of this study was to determine the efficacy of gabapentin as adjunctive therapy in doses required to achieve the most effective seizure control. "
01/01/2004 - "The preliminary findings of this study suggest that gabapentin is very effective against tonic-clonic seizures in alcohol withdrawal syndrome. "
08/01/2006 - "More gabapentin patients reported moderate to marked improvement in seizure frequency and intensity/duration of each seizure than placebo patients. "
08/01/2006 - "Gabapentin 1200 mg/day and 1800 mg/day significantly reduced the frequency of refractory seizures compared to placebo. "
12/01/1995 - "Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large double-blind, placebo-controlled, parallel-group clinical trails. "
01/01/2013 - "Gabapentin and tricyclic antidepressant are effective in postherpetic neuralgia. "
11/01/2001 - "Thus, this study confirms the role of gabapentin as an efficacious and well-tolerated treatment for postherpetic neuralgia."
04/01/1996 - "Gabapentin as a novel treatment for postherpetic neuralgia."
09/01/2012 - "The efficacy of once-daily gastroretentive gabapentin for the management of postherpetic neuralgia has been demonstrated in placebo-controlled clinical studies. "
12/01/2013 - "Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over."
09/01/1997 - "Although the spectrum of efficacy of gabapentin remains to be determined, it is likely to have a major beneficial impact on the treatment of childhood epilepsy."
01/12/2005 - "Gabapentin at a dosage of 1200 mg/d is safe and effective in treatment of epilepsy."
01/12/2005 - "To assess the safety and efficacy of gabapentin in treatment of refractory epilepsy. "
12/01/2003 - "Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients."
10/01/2014 - "The study was aimed to prepare and evaluate gabapentin loaded albumin nanoparticles and to find out their effectiveness in treating epilepsy. "
|4.||Anticonvulsants (Antiepileptic Drugs)
|7.||Opioid Analgesics (Opioids)
|9.||Valproic Acid (Valproate, Semisodium)
|10.||Morphine (MS Contin)
|2.||Drug Therapy (Chemotherapy)
|5.||Psychology Biofeedback (Biofeedback)